FMP

FMP

Enter

NRSN - NeuroSense Therapeut...

Financial Summary of NeuroSense Therapeutics Ltd.(NRSN), NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and d

photo-url-https://financialmodelingprep.com/image-stock/NRSN.png

NeuroSense Therapeutics Ltd.

NRSN

NASDAQ

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

1.6 USD

-0.05 (-3.12%)

About

ceo

Mr. Alon Ben-Noon

sector

Healthcare

industry

Biotechnology

website

https://www.neurosense-tx.com

exchange

NASDAQ

Description

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

CIK

0001875091

ISIN

IL0011809592

CUSIP

M74240108

Address

Building B

Phone

972 9 799 6183

Country

IL

Employee

18

IPO Date

Dec 9, 2021

Summary

CIK

0001875091

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

M74240108

ISIN

IL0011809592

Country

IL

Price

1.6

Beta

1.56

Volume Avg.

310.95k

Market Cap

27.73M

Shares

-

52-Week

0.4-2.33

DCF

0.19

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.93

P/B

-

Website

https://www.neurosense-tx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest NRSN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep